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with three different expanders. TRIAL DESIGN Three-arm parallel randomized clinical trial. METH-
ODS Sixty-six patients, 10-16 years old, in permanent dentition, with maxillary transverse deficiency
were recruited and assigned with block randomization (1:1:1 ratio) and allocation concealment to three
groups of 22 patients each (Hyrax, Hybrid-Hyrax, and Keles keyless expander). The primary outcome
(overall upper airway volume change) and secondary outcomes (volume changes in the nasal cavity, na-
sopharynx, oropharynx, and hypopharynx) were blindly assessed on the initial (T0) and final (T1, 6
months at appliance removal) cone beam computed tomography. Differences across groups were assessed
with crude or adjusted for confounders (gender, age, growth stage, skeletal pattern, baseline airway vol-
ume, and amount of expansion) linear regression models. RESULTS Fifty-one patients were analysed
(19, 19, and 13 in the Hyrax, Hybrid-Hyrax, and Keles groups). Maxillary expansion resulted in con-
siderable increases in total airway volume in the Hybrid-Hyrax group (+5902.1 mm3) and less in the
Hyrax group (+2537.9 mm3) or the Keles group (+3001.4 mm3). However, treatment-induced changes
for the primary and all secondary outcomes were of small magnitude and no significant difference was
seen among the three expanderes in the total airway volume in either crude or adjusted analyses (P >
0.05 in all instances). Finally, among pre-peak patients (CVM 1-3), the Hybrid-Hyrax expander was
associated with significantly greater increases in total airway volume compared to the Hyrax expander (P
= 0.02). CONCLUSIONS RME resulted in relatively small increases in total upper airway volume and
its separate compartments, with mostly no statistically significant differences across the Hyrax, Hybrid-
Hyrax, and Keles groups. LIMITATIONS Significantly greater attrition was found in the Keles group
due to appliance failure. The current trial might possibly be under-powered to detect differences between
groups, if such exist. HARMS Keles expanders blocked during activations and required substitution
for completion of treatment. PROTOCOL The protocol was not published before trial commencement.
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Summary 
Objective: To assess upper airway volume changes after rapid maxillary expansion (RME) with three 
different expanders. 
Trial design: 3-arm parallel randomised clinical trial. 
Methods: Sixty-six patients 10-16 years old, in permanent dentition, with maxillary transverse 
deficiency recruited and assigned with block-randomisation (1:1:1 ratio) and allocation concealment to 
three groups of 22 patients each (Hyrax, Hybrid-Hyrax, Keles keyless expander). The primary outcome 
(overall upper airway volume change) and secondary outcomes (volume changes in the nasal cavity, 
nasopharynx, oropharynx, hypopharynx) were blindly assessed on the initial (T0) and final (T1, 6 
months at appliance removal) Cone Beam Computed Tomography (CBCTs). Differences across-
groups were assessed with crude or adjusted for confounders (gender, age, growth stage, skeletal 
pattern, baseline airway volume, and amount of expansion) linear regression models. 
Results: Fifty-one patients were analysed (19, 19, and 13 in the Hyrax, Hybrid-Hyrax, and Keles 
groups). Maxillary expansion resulted in statistically significant increases in total airway volume only in 
the Hybrid-Hyrax group (+5902.1 mm3; P<0.001), but not in the Hyrax group (+2537.9 mm3; P=0.11) or 
the Keles group (+3001.4 mm3; P=0.34). However, treatment-induced changes were of small magnitude 
and no significant difference was seen in the total airway volume in either crude or adjusted analyses 
(P>0.05 in all instances). Similarly, no statistically significant differences in the treatment-induced 
changes for any of the secondary outcomes were found across groups. 
Conclusions: RME resulted in relative small increases in total upper airway volume and its separate 
compartments, with no statistically significant difference across the Hyrax, Hybrid-Hyrax, and Keles 
groups. 
Limitations: Significantly greater attrition in the Keles group due to appliance failure. The current trial 
might possibly be under-powered to detect differences between groups, if such exist. 
Harms: Keles expanders blocked during activations and required substitution for completion of 
treatment.  
Protocol: The protocol was not published before trial commencement. 




Rapid maxillary expansion (RME) appliances are often used to treat transverse deficiencies in the 
maxilla since their introduction in the 1860s (1) with both skeletal and dentoalvoelar effects (2). Two of 
the most commonly used RME designs include the Hyrax and Haas expanders, which however are also 
associated with undesirable tooth movement and tipping due to the way forces are applied (3). RME 
appliance activation with an external key may be a challenge as patients, parents or guardians may find 
it difficult to use and require external help. Furthermore, the key may potentially be an aspiration hazard 
(4) as well cause lacerations to the palatal mucosa, if used incorrectly. As a result, the development of 
an effective keyless expander could be beneficial and patient friendly regarding cooperation with the 
activation scheme. In the last decade attempts have been made to incorporate skeletal anchorage 
devices to the RME appliance, in an effort to minimize its dentoalveolar and increase its skeletal effects 
(5). Nonetheless, the increased invasiveness of the procedure, possibility of the loss of the anchorage 
devices, and the risk of infection (6-8) have restricted the widespread use of skeletally-anchored RME.  
The impact of orthodontic treatment on the airways has received increased interest in the latter 
years with studies showing that, in addition to its orthodontic effects, RME can have a positive effect on 
airway dimensions and breathing function (9). The mechanism of action is believed to derive from the 
increases of nasal width with subsequent enlargement in upper airway volume and decrease in nasal 
resistance (9, 10). A significant increase in nasal airflow and reduction in airway resistance were found 
with Hybrid-Hyrax expanders using rhinomanometry immediately after expansion (11). These beneficial 
effects of RME have been highlighted as a therapeutic possibility in children diagnosed with obstructive 
sleep apnoea, who showed reduction in the Apnoea-Hypopnea Index (AHI) after RME treatment (12).  
The upper airway has been traditionally measured using two-dimensional imaging (lateral 
cephalometric radiographs); however, there are considerable limitations of measuring a three-
dimensional volume from a two-dimensional image (13). Advances in three-dimensional imaging 
(magnetic resonance imaging, computed tomography, and Cone Beam Computed Tomography 
[CBCT]) have allowed better visualisation and reliable analysis of the airway volumes (13-15). Several 
studies have investigated airway changes after RME using CBCT (16-20). Cordasco et al 2012 
evaluated retrospectively a sample of eight children receiving maxillary expansion with a conventional 
tooth-borne expander while the area of interest and subsequent linear and volumetric measurements 
were performed and confined to the nasal cavity only (16). Gorgulu et al 2011, included similarly one 
group of 15 patients aged 12-16 years, all of whom received a bonded tooth-borne expander with acrylic 
coverage and airway measurements were basically focused to the nasal cavity (17). Another study 
investigated the changes induced in the nasal airway volume by a tooth anchored acrylic cap splint 
appliance with a hyrax screw in 10 Class I and 14 Class II children of 14.5 years of age (18). Even 
though Smith et al 2012 investigated treatment changes due to RME (banded in 1st permanent premolar 
and molars) in all upper airway compartments, the use of only one appliance design does not permit 
comparisons with any other type of expanders and the retrospectivity of the study comes with the 
relevant biases in study design (19). With the introduction of skeletal anchorage, purely bone-bone 
appliances such as the Dresden Distractor have been used in conjunction to Surgically Assisted rapid 
Maxillary Expansion (SARME) in adult patients (20). Further to this, comparison of upper airway 
changes after RME with a Hyrax expander and a purely bone-borne expander was performed through 
Acoustic Rhinometry in growing individuals (21) while a hybrid appliance anchored to the 1st permanent 
premolars and molars and 4 miniscrews (1.8x7mm) was assessed in 14 adults using CBCTs (22). 
Evidence from the literature depicts that the available studies render issues relevant to study design 
such as randomisation, allocation of treatment, blinding of the assessors during measurements, 




The aim of this study was to assess the short-term changes in upper airway volume after RME with 
conventional tooth-borne (Hyrax), tooth-bone-borne (Hybrid-Hyrax), and the Keles keyless expander 
via CBCT. 
 
Subjects and methods 
Trial design and any changes after trial commencement. 
This was a single-centre double-blind (outcome assessor and data analyst) parallel randomised 
controlled trial with a 1:1:1 allocation ratio. 
 
Participants, eligibility criteria, and settings 
The sample consisted of 66 healthy 10-16 year-old patients recruited from the orthodontic waiting list 
at Sydney Dental Hospital by the authors (G.C.C, S.M and S.H) from January 2017 to July 2017. The 
following inclusion criteria were applied: unilateral or bilateral posterior crossbite; maxillary transverse 
deficiency of >5mm as measured from the cusp of the upper first permanent molars to the lower first 
permanent molar central groove; erupted first permanent molars and premolars; adequate oral hygiene; 
no history of previous orthodontic treatment and no history of craniofacial defects, syndromes or 
surgery. Consent was obtained from the patients (and the parents of patients were adolescents before 




Prior to orthodontic intervention, full records were taken for each patient constituting of study models, 
extra-oral photos, and intra-oral photos. Each patient was then randomised to a Hyrax, Keles or Hybrid-
Hyrax RME appliance (Figure 1). At the first appointment, patients were informed about their treatment 
allocation, received their baseline CBCT (T0) and separators were placed between the contact points 
of first premolars and molars. Approximately a week later, molar/premolar bands were fitted and 
alginate impressions taken for expander fabrication. Patients in the Hyrax and Keles groups received a 
traditional Hyrax (Hyrax, Dentaurum, Ispringen, Germany) and Keles keyless expander (Keles, Istanbul, 
Turkey) soldered to bands on the first premolars and molars respectively. In patients allocated to the 
Hybrid-Hyrax group, 1.0ml Lignocaine-1:80,000 adrenaline was administered as a local anaesthetic 
infiltration in the anterior palatal area. A sterile gauze soaked in chlorhexidine was used to disinfect the 
palate in the area of insertion. Following this, predrilling was performed using a PSM Medical Solutions 
(Tuttlingen, Germany) drilling bur adapted to a contra-angle handpiece and rotated by hand to a depth 
of 7mm at a 90-degree angle to the palate at approximately the area of the third palatal rugae. Two 
Benefit miniscrews of length 9mm and 2mm width (PSM Medical Solutions, Tuttlingen, Germany) were 
placed bilateral to the midpalatal suture. Bands were fitted on the first permanent molars only and 
alginate impressions were taken using impression copings. Patients were instructed to use 
chlorhexidine mouthwash twice a day for one week, with gentle brushing of the miniscrews. 
All appliances were inserted approximately 2 weeks after the impression appointment, with 
bands cemented using multi-cure Glass ionomer cement (3M Unitek, Maplewood, Minnesota). Patients 
were instructed to turn the expander twice a day (0.5mm) and to return for weekly reviews until palatal 
cusps of the upper first molars were in contact with the buccal cusps of the lower first molars. The 
expander was then locked and the patient instructed to return in 6 months unless there were any 
breakages. At 6 months, the appliances were removed and full records were taken including a second 
CBCT (T1). Treatment was provided by three providers (G.C.C., S.M. and S.H.). 
CBCT images were taken using a NewTom 5G (Cone Beam 3D Imaging, Verona, Italy) imaging 
system at 110kV, 20mAs, 18x16cm, 0.3mm voxel size and 3.6 seconds per section with patients in a 
supine position. Head position was controlled by manually positioning the patient so that the Frankfort 
horizontal plane was perpendicular to the floor and patients instructed to stay still during the scan. For 
image acquisition and throughout the scanning process, patients were instructed after expiration to be 
in centric occlusion with the lips and tongue in resting position and not to swallow. Patients did not 
receive any orthodontic treatment during the study period; however, all additional to the constricted 
maxilla problems were addressed after completion of the present study.  
 
Outcomes (Primary and Secondary) and any changes after trial commencement 
The main outcome was the treatment-induced (T1-T0) changes in the overall airway dimension as 
measured on CBCT after expander use. The secondary outcomes included changes in the separate 
compartments of the airway: nasal cavity, nasopharynx and oropharynx between devices. A sensitivity 
analysis was also run by calculating changes in the overall ‘functional’ airway volume – the total airway 
without including the sinus volumes. Airway changes were assessed against factors such as baseline 
airway, gender, age, Cervical Vertebrae Maturation (CVM) stage, expansion width calculated by the 
days of expansion from the patients’ calendars, anteroposterior (SNA, SNB, ANB, Wits, convexity), 
vertical (mandibular plane angle SN-MP) and linear depth (SN, Co-A, Co-Gn) of the craniofacial 
morphology. 
The reconstructed CBCT datasets were imported into the Dolphin 3D software (Dolphin 
Imaging, Chatsworth California, USA) as Digital Imaging and Communications in Medicine (DICOM) 
files. The files were then provided with a number by a third party uninvolved with the study so that the 
assessor (G.C.C.) was blinded to the patient and time points while performing the measurements. 
All images were orientated prior to landmark identification. The sagittal plane was orientated in 
the Frankfort horizontal plane, with the coronal and axial plane orientated to the skeletal midline using 
the crista galli, anterior nasal spine, nasal bone and orbits as reference points (Figure 2). The 3-
dimensional (3D) landmarks were based on landmarks used in previous studies for measurement of 
the 3D airways for the nasal cavity, nasopharynx and oropharynx (19, 23-25). The definitions for the 
airway boundaries are described in Table 1. In the Dolphin software, the boundaries of the nasal cavity, 
nasopharynx, oropharynx and hypopharynx were first located on the mid sagittal position in the coronal 
view (Figure 3, marked A, B, C, D respectively). The sinuses were outlined on coronal view at the 
section of the furcation of the maxillary first molar (Figure 3, marked E). Seed points were then placed 
in all air cavities within the boundaries. This included all sinuses and ethmoid air cells within the total 
airway boundaries. The images were cross checked in all three planes of place (sagittal, coronal and 
axial) and new seed points placed when required to ensure that all air cavities were included. The 
sensitivity threshold was kept to the maximum possible for each patient without detecting space outside 
the airway. Individual sensitivity thresholding was achieved for each sample by manually adjusting the 
threshold until the maximum threshold setting could be used without detecting space outside the 
anatomical limits of the airway. A starting threshold setting of 40 was used and this was changed 
incrementally until the highest threshold was reached. This was defined as when the 3D reconstruction 
of the airway demonstrated the correct airway morphology with no reconstruction of the space around 
the head. A threshold range between 50-70 was used for all scans (26, 27).  
 
Error measurement 
To examine measurement reliability and agreement, 25% of the sample was randomly selected and 
remeasured after 4 weeks. This involved reorientation of all images and reselection of the sensitivity 
threshold value for segmentation. The concordance correlation coefficient (28) and Bland-Altman 
method (29) were used to test intra-examiner reliability and agreement. 
 
Sample size calculations 
Sample size calculations were based on the ability to detect a clinically relevant difference of a 20% 
increase in airway volume, α = 0.05 and a power of 80% in a 2-sided paired t-test. A mean of 23950mm3 
and standard deviation of 6431mm3 data from a previous study using similar airway volume parameters 
were used (19). This resulted in a sample size required of 15 patients per group. Twenty-two patients 
per group were chosen to be the final sample size to accommodate for dropouts and any possible image 
quality DICOM dataset issues that would have compromised the reliability of measurements. 
 
Interim analyses and stopping guidelines 
Predetermined factors for terminating and/or modifying treatment for patient safety reasons were the 
following: unresponsive tissues to expansion such as excessive buccal tipping with mobility of anchor 
teeth accompanied with lack of midline diastema after 1 week of expansion, appliance breakage, 
miniscrew infection and complete failure.  
 
Randomisation (random number generation, allocation concealment, implementation) 
Randomisation was accomplished using the “RANDBETWEEN” command in Excel 2016 software 
(Microsoft, Washington) to randomize patients into the three groups as blocks of 22 patients each. 
Allocation concealment was performed by a staff member at the Sydney Dental Hospital not directly 
involved with the trial. Separate sealed and opaque envelopes with each patient’s allocation were held 
in a central location in the department until the day of treatment. 
 
Blinding 
The patient and operators could not be blinded to the intervention groups during treatment. Each CBCT 
dataset was given a coded ID number, with the de-identified coding list kept by staff not involved in the 
measurements and was released during dataset preparation. The datasets were provided with codes 
on the expander type (expander 1, 2, and 3) and time-points (time-point a and b) for blinded statistical 
analysis and the code was broken after supplying the results of the statistical analysis. 
 
Statistical Analysis (primary and secondary outcomes, subgroup analyses) 
Initially, descriptive statistics were calculated including absolute/relative frequencies (for categorical 
outcomes) or means and Standard Deviations (SDs) (for continuous outcomes). Afterwards, crude 
differences across experimental groups were assessed with one way analysis of variance and Fisher’s 
exact test. Explorative linear regression models were constructed to assess the possible influence of 
patient age, gender, Cervical Vertebrae Maturation (CVM) stage, baseline cephalometrics of skeletal 
pattern, pre-expansion airway volume, and expansion width on the treatment-related T1-T0 change in 
total airway volume. Finally, the effect of expander type on total airway volume at T1 with volume at T0 
as covariate was assessed with either crude analysis or adjusting for any confounders. Interactions of 
confounders with expansion group were tried and dropped if not statistically significant (P>0.05). 
Significant interactions were further explored with stratified analyses. All analyses were run in Stata SE 
13.0 (StataCorp, College Station, TX) with significance level set at a two-sided 5% and the dataset 
openly provided through Zenodo (30).  
 
Results 
Participant flow and recruitment 
The patient flow in this study is demonstrated by the CONSORT flow diagram in Figure 4. All 66 patients 
who were deemed eligible for treatment were randomised in a 1:1:1 ratio to Hyrax, Hybrid-Hyrax or 
Keles expander. Patient recruitment started January 2017 and was completed in July 2017.  
 
Numbers analysed for primary outcome and subgroup analysis. Baseline data 
In the Keles group, 8 patients were excluded from the study and were further treated with a Hyrax 
expander. This was deemed necessary as it was found that their Keles keyless expanders suffered 
from structural defects related to blocking of the expander not permitting further activations, which made 
it clinically unsatisfactory to continue their use. It was decided that it would be unethical to continue. 
The expanders were replaced and these cases were excluded from the analysis. Additionally, 2 DICOM 
datasets form the Hyrax group and 3 from the Hybrid-Hyrax group were not of appropriate quality for 
performing upper airway measurements, due to patient movement during image acquisition, making 
further analysis not feasible. This resulted in a total of 51 remaining patients (19, Hyrax, 19 Hybrid-
Hyrax, 13 Keles expander) that had CBCT images analysed for both time points, leaving a total of 102 
datasets. Baseline data characteristics of the analysed patients show no significant differences between 




The concordance correlation coefficient was 1.00 (95% CI: 1.00-1.00) and the average differences of 
the repeated measurements was -52.39 mm3 (95% limits of agreement -1029.29 to 924.51 mm3; 
Bradley-Blackwood P=0.81), indicating excellent intra-examiner reliability and agreement.  
 
Primary outcome 
Table 3 shows the volumetric changes between T0-T1 within and among the Hyrax, Hybrid-Hyrax, and 
Keles expander groups. The total airway volume showed the greater increase after treatment in the 
Hybrid-Hyrax group (5902.1±5992.9mm3; +8.3% from T0), followed by the Keles group 
(3001.4±10909.9 mm3;+4.5% from T0), and the Hyrax group (2537.9±6603.7 mm3; +3.8% from T0) with 
no statistically significant differences across the three RME groups for the total airway.  
 
Secondary outcome 
Similarly, no significant differences were seen between the groups for the total airway volume without 
including the sinuses (P=0.26). On average, more pronounced changes in all airway compartments 
were most of the time seen for the Hybrid-Hyrax group or the Keles group compared to the Hyrax group 
(Table 3). However, no significant difference was seen for any of the airway compartments across the 
three groups with the sole exception of nasopharynx exhibiting greater changes in the Keles group 
(P=0.04).  
Exploring potential confounders across the whole sample, baseline airway volume at T0 was 
significantly associated in an inverse manner with the amount of treatment-induced (T1-T0) increases 
seen (P=0.02), while patient age, CVM stage, anteroposterior (SNA, SNB, ANB, Wits, NA-A-Pog), 
vertical (SN-ML) and linear (cranial base-SN, relative maxillary Co-A and mandibular Co-Gn lengths) 
cephalometric variables were also investigated as potential confounders (Supplementary Table 1). 
Controlling with adjusted analyses for most confounders on the effects of the different 
expanders (Supplementary Table 2) showed that no significant difference was seen between the three 
expanders. However, a significant interaction term of the patients’ CVM stage with the expander groups 
was found, which was further assessed by stratified analysis (Supplementary Table 3). This indicated 
that among pre-peak patients (CVM 1-3), the Hybrid-Hyrax expander was associated with significantly 
greater increases in total airway volume compared to the conventional Hyrax expander (P=0.02). 
 
Harms 
Minor discomfort and infection were associated in some patients due to miniscrews placement; 
however, this resolved after using chlorhexidine mouthwash and reinforcement of correct oral hygiene 
protocols. The Keles expander showed issues related to the activation rod, which became immobile 
and rendered further expansion inevitable. Patients whose Keles appliances exhibited the above issues 
had their devices substituted with Hyrax expanders for completion of treatment. Additionally, due to 
tipping of the anchor teeth in the Keles expander group, which was noted clinically during the weekly 
follow-ups of active treatment, activation was performed until posterior crossbite correction without 
attempting overcorrection (Table 2, amount of expansion).  
 
Discussion 
In this double-blinded randomised clinical trial CBCT data were used to evaluate the volumetric 
compartmental changes of the airway using two tooth-borne and one tooth-bone-borne expander. RME 
expansion treatment has been demonstrated to have a positive effect in airway change (19). The 
development of new expanders supported by TADs may have increased benefits on upper airway 
change as increased nasal flow rates and reduced resistance using tooth-bone-borne expanders was 
found when compared to tooth-borne expanders (4, 11). To the author’s knowledge, no RCT using 
CBCT has been conducted to assess the volumetric changes between tooth-bone-borne and tooth-
borne expanders. Therefore, the purpose of this study was to investigate and compare the effect of 
different types of expanders on the upper airway volume. 
The use of three-dimensional volumetric data in this study has allowed us to overcome the 
limitations of analyses on two-dimensional lateral cephalograms. A number of studies have investigated 
the effects of rapid maxillary expansion on nasal cavity width, nasal resistance and airflow and have 
found increases in favourable results (31, 32). Nonetheless, anatomic changes were assessed in 
postero-anterior radiographs, which is a questionable method regarding its specificity in measuring a 
3D entity such as the nasal cavity and the rest of the upper airway volume (13). A systematic review 
and meta-analysis on volumetric upper airway changes with tooth-borne RME reported an increase of 
1218.3mm3 in the total upper airway immediately post-expansion and in the nasal cavity. Nevertheless, 
many studies reported on miniscule clinically irrelevant changes from baseline, while the overall quality 
of evidence was low due to study design, lack of controls and inconsistency of boundaries set for the 
measurements amongst researchers (33). Especially the latter issue makes comparison between 
articles difficult, with as many as six different definitions published for just the superior anatomical 
boundary of the nasopharynx showing lack of consensus in the literature (34).  
Airway changes after RME using a Hyrax expander have also been investigated by other 
researchers (19), who have reported statistically significant increases in the volume of the nasal cavity 
and the nasopharynx (19). This differs from the findings of the present study and may be due to the 
younger cohort group as well as the short duration (3 months) before obtaining the post-treatment scan. 
In another retrospective study, both tooth-borne Hyrax and a purely skeletally anchored expander used 
in patients of similar age to the ones recruited in the present study resulted in significant changes in the 
nasal cavity and nasopharyngeal volumes (35). Even though their bone-bone expander created greater 
effects, these did not reach statistical significance, a finding which is in agreement to our comparisons 
between the three expanders. This could be due to the considerably variable response to RME across 
patients, which indicates that not all patients treated with RME might experience the same increase in 
airway volumes. However, both studies showed significant changes induced with the Hyrax in the nasal 
cavity and nasopharynx, which differs to our results on the Hyrax group. This could possibly be 
attributed to inter-individual patient anatomic factors and appliance construction characteristics. When 
the effects of palate depth, modified arm shape and anchor screw on RME expansion were tested with 
finite element analyses (FEA), it was reported that deep palate exhibited smallest RME effects, smallest 
midpalatal suture expansion and greatest arm strain. Additionally, arms of larger diameter, with diagonal 
connections, straight and short create more efficient maxillary expansion and are necessary even in the 
presence of skeletally anchored expanders (36).  
In the present study, a tendency towards greater changes was found in the Hybrid-Hyrax group. 
FEA has been extensively used to assess stress distribution in various RME appliances. 
Superimposition of FEA models simulated to real expansion data derived from Hybrid-Hyrax CBCTs 
showed expander arm deformations and enormous stresses around miniscrews. Stresses were mainly 
concentrated around the Le Fort I plane and were greater in the infrazygomatic crest and the 
pterygomaxillary complex while there was lack of stresses around the molar anchor teeth (37). Similarly, 
RME anchored on micro-implants placed in various areas of the palate showed stress concentrations 
around the implants whereas stresses were still present on teeth even when surgically assisted RME 
was simulated in conjunction with the tooth-borne expanders (38). Comparison of the stresses 
generated on the craniofacial structures by tooth-anchored and implant-supported RME showed that 
the former generated greater stresses on teeth and the later to the midpalatal and circumaxillary sutures 
(39). Based on the above literature, the tendency of the Hybrid-Hyrax to perform better in the nasal 
cavity and the total airway in our study could be attributed to the palatal implants, which most probably 
withstand the stresses developed during expander activation, and not to the different maturation levels 
of the midpalatal suture, which do not affect RME outcomes (40). The fact that these differences did 
not reach statistical significance in the inter-group comparison in our study, except for pre-peak patients, 
could be possibly due to an insufficient sample able to detect between group differences because the 
sample size calculations were focused to identify pre- and post-expansion changes; however, the 
results from the present RCT could be utilised for designing further research in this topic.  
The design of the Keles expander was such that it was positioned much lower in the palate 
than either the Hyrax or Hybrid-Hyrax expander. This may explain why the oropharynx had a statistically 
significant change only in the Keles group which differs from published studies that found no changes 
in the oropharynx after rapid maxillary expansion (41). As the final CBCT scan was taken at appliance 
removal, the low position of the Keles expander may have trained the tongue to be in an altered position. 
It has been demonstrated that the tongue position can impact on orpharyngeal volumetric dimensions 
(42); however, long term follow-up would be required to assess if this altered tongue position is retained 
after removal of the appliance. 
Controversy also exists with regards to the anteroposterior and vertical relationships of the 
craniofacial region and the airways. In dolichofacial and brachyfacial Class II children, the size of the 
upper airway did not differ statistically between facial types; however, the simulated with Computational 
Fluid Dynamics (CFDs) maximal pressure and velocity of the dolichofacial type were significantly higher 
to the brachyfacial type. Even though the depth and cross-sectional area of the airway did not exhibit 
morphologic differences, airway obstruction differed between different vertical phenotypes (43). The 
anteroposterior and vertical skeletal craniofacial morphology has not been significantly related with 
airway dimensions in Class Is, IIs and IIIs (44, 45); however, functional analyses showed significantly 
larger nasal resistance in Class II versus Class IIIs, correlated also with inferior tongue posture and 
decreased intermolar width (46). Other studies though showed greater airway volume in Class IIIs 
compared to Class Is and Class IIs (47) with the oropharyngeal airway being large and flat in Class IIIs 
as opposed to Class Is (48) and IIs (49). In the present study, anteroposterior and vertical craniofacial 
characteristics did not have significant effects on the upper airway changes both in the whole sample 
and when testing for any differences between expanders.  
As far as the reliability of the measurements is concerned, different scanning timings of the 
same patients resulted in different pharyngeal airway space values indicating the need for controlled 
and standardised patient positioning for reducing such inconsistencies; however, when the scans of the 
same time point were repeatedly measured by the same investigators, CBCT airway measurements 
showed high and adequate repeatability, which corroborates to our measurement error results (50). 
Significant methodological issues that could affect the reliability of airway measurements using CBCT 
are the lack of manual orientation of the images and selection of threshold sensitivity (51). 
Notwithstanding, the intra-examiner reliability improves with experience and is more consistent between 
examiners who are more educated and experienced in measuring the upper airways (52).  
Dolphin’s software automatic tool accuracy and reliability in airway analysis differed from 
manual segmentation by 9 to 43% meaning that the automatic tool is not accurate or reliable enough 
unless the scanning properties are conditioned, the measurements are standardized and the delineated 
airway is evaluated visually and uniformly by the observer (53). Threshold value standardisation or 
adjustment per individual case has been another parameter of debate. An ideal range of threshold 
values between 70 and 75 has been reported under laboratory conditions of an engineered 
homogenous prototype (27); however, this approach of applying strictly standardized threshold values 
does not take into account that tissues surrounding the upper airways may vary between patients with 
regards to their properties and subsequently the threshold values may need to be adjusted manually 
for each individual and not to rely on the softwares’ automatic settings. No method or software comes 
without an expense, with automatic segmentation and thresholds leaving empty spaces within the 
rendered volumes while manual segmentation with operator controlled thresholds may overflow volume 
into another region (26). The threshold values in our study were manually adjusted and the range was 
50-70. All scans were acquired by a specialist maxillofacial radiologist who followed the standardised 
protocol in patient positioning and instructions given to patients prior to scanning. In addition, the person 
performing the CBCT measurements developed a calibration through extensive experience, which was 
reflected in the agreement of repeated measurements.  
 
Limitations 
Like most longitudinal studies, there was attrition in each group, which was considerably higher in the 
Keles group due to technical failures of the appliance. This reduced number of patients in that group 
was less than the a priori calculated minimum sample of 15 patients/group needed to achieve sufficient 
power of the study. Subsequently, this may explain the lack of significant differences for the Keles 
appliances, which there might be there. The lack of statistically significant differences between devices 
in changing the airway volume between T0 and T1 indicates differences of small magnitude that might 
not be necessarily clinically relevant; however, a study with a larger sample size will be required to 
confirm these findings. 
 Additionally, it must be here stressed out that any benefits in term of increased airway volume 
obtained from RME are not necessarily translated in improved function for breathing-disordered 
patients. Neither adeno-tonsillectomy nor RME alone produce satisfying results, and only their 
combination leads to clinically relevant improvement in clinical and polysompographic outcomes (54). 
There are currently limited long-term data to justify the efficacy of dentofacial orthopaedics for paediatric 
sleep apnea (55), even though short-term evidence hints that RME might lead to improved quality of 
life of children with narrow maxilla and mild sleep apnea (56). All the above corroborate that there is 
currently insufficient robust data to support in an evidence-based manner the use of RME for the 
treatment of obstructive sleep apnea (57). Such recommendations can only be founded on sound 
clinically-relevant outcome such as improvements in morbidity rate, AHI, or the Eppworth Sleepiness 
Scale. 
Although the accuracy of the CBCT in airway measurement is relatively well established (32), 
during the course of this research, a large degree of variation was seen in the sinus measurements 
possibly due to sinus inflammation with the most severe case demonstrated in Figure 5. This questions 
the validity of using CBCT to measure sinuses in patients with soft tissue inflammation; however, when 
we further analysed the total airways by excluding the values of the sinuses, results on total airways 
did not change for any group exclusion of the sinuses did not considerably impact the results. 
Additionally, random variation inherent to CBCT imaging of the upper airway, which can be due to 
operator errors in patient positioning within the tomograph and patient related parameters relevant to 
breathing or swallowing phases, was minimised by following a strictly controlled and standardized 
protocol combined with detailed patient instructions for image acquisition (34, 50); however, it is not 
possible to fully be aware if the patients followed the given instructions.  
The upper airway undergoes rapid growth during the first 3 years of life, then growth slows in 
rate and a second rapid growth phase occurs in adolescence (58). As our sample was within the 
adolescent growth spurt, the factor of growth cannot be fully ruled out; however, acquiring CBCTs from 
healthy, untreated controls within a 6 month interval cannot be justified for ethical reasons.  
Finally, our patients have not been assessed by ENT specialists prior or after completion of the 
study for adenoids, tonsil size and any other kind of airway obstructions caused by mucosal and/or 
nasal conchae hypertrophy. As adenoid and tonsil sizes can be negatively correlated with the 
oropharyngeal airway in both Class IIs and Class IIIs (46) while nasal obstructions have been found to 
cause significant increases in maximum airflow velocity, inspiratory pressure drop and insipratory 
pressure loss coefficients in Continuous Positive Airway Pressure (CPAP) patients (59), it is obvious 
that the presence of such discrepancies would have an effect in the results. This could also be a 
possible explanation of the great inter-individual variability and range in the response to treatment as 
expressed in the great standard deviations, sometimes even 2 or 3 times above the mean difference 
seen in the total airway for the Hyrax and the Keles groups. For developing evidence-based 
recommendations, the European position paper on diagnostic tools in rhinology has reviewed and 
described several tools used to assess airway obstruction and concluded on the importance of prompt 
and accurate diagnosis for the appropriate management of sinonasal disease (60). Nevertheless, the 
readily available and traditional diagnostic approaches such as peak nasal inspiratory flow and acoustic 
rhinometry minimal cross-sectional area fail to meet the criteria of an ideal diagnostic test for breathing 
(61), which indicates a lack of consensus within medical specialities that have breathing assessment 
and upper respiratory organ function within their scope of practice. 
The sample of the present study represents a random sample of an everyday clinical practice 
and thus it further substantiates that RME neither can be considered a sole and effective measure for 
increasing upper airway dimensions nor it can be simplistically related with improved breathing. 
 
Generalizability 
For any adolescent patient undergoing orthodontic treatment, growth is always a confounding factor 
impacting on results. As there were no controls in this trial, it was difficult to ascertain the impact that 
growth may have on the airway volumetric change. Nonetheless, the randomization process which 
resulted in each patient having an equal chance of receiving any of the three devices resulted in a 
similar distribution of confounding variables in each group. As the treatment and assessment protocol 
were completed within a short time frame, the amount of growth as a confounding variable was also 
minimised. With the inclusion and exclusion criteria used in this trial, the patients treated in this study 
were similar to most orthodontic caseloads. Nonetheless, the patients of the present study were on 
average older to the ones usually receiving RME. This is due to the long public waitlists at the Sydney 
Dental Hospital. Theoretically though, the use of an older patient cohort could further demonstrate the 
effectiveness of the Hybrid-Hyrax expander in increasing the upper airway volume. Therefore, the short-
term results of the present study are applicable to adolescent patients 10-16 years of age with maxillary 
transverse deficit.  
 
Conclusion 
All three RME appliances produce relatively small increases in the total volume of the upper airway 
(Hyrax: 3.8%, Hybrid-Hyrax: 8.3%, Keles expander: 4.5%), which casts doubts about their clinical 
relevance. No statistically significant differences were seen among the three appliances either for 
overall airway volume or for the volume of each specific airway compartment, with the sole exception 
of the nasopharynx. For all three expanders, greater changes were noted in patients with small baseline 
airway volumes. CVM stage had a significant impact on the effect of RME on airway volume, where 
pre-peak patients (CVM stages 1-3) experienced greater increases in total airway volume. Finally, 
among pre-peak patients, greater total airway increases were seen with Hybrid-Hyrax than with 
conventional Hyrax expanders.  
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Figure legends 
Figure 1. Expander design used in this study: Keles keyless expander (A), Hyrax expander (B), TAD 




Figure 2. CBCT orientation prior to analysis. The sagittal plane was orientated in the Frankfort 
horizontal plane, with the coronal and axial plane orientated to the skeletal midline using 




Figure 3. Boundaries used for the division of the airway taken in the sagittal section at the mid 
sagittal plane: Nasal cavity (A), Nasopharynx (B), Oropharynx (C) Hypopharynx (D). 









Figure 5. Three dimensional (3D) representations of the sinuses of the same patient at T0 (A) and 
T1 (B). The marked differences in the sinus volume of the left sinus are notable and could 





Table 1. Definition of the anatomic upper airway compartments in the sagittal view. 
 Anterior boundary Posterior boundary Superior boundary Inferior boundary 
Nasal cavity Line from Anterior Nasal Spine 
(ANS) to the tip of the nasal 
bone to Nasion (Na) 
Line from Sella (S) to 
the Posterior Nasal 
Spine (PNS) 
Line from Nasion (N) 
to Sella (S) 
Line from Anterior Nasal 
Spine (ANS) to the 
Posterior Nasal Spine 
(PNS) 
Nasopharynx Line from Sella (S) to the 
Posterior Nasal Spine (PNS) 
Line from Sella (S) to 
the tip of the odontoid 
process 
 Line from Posterior nasal 
Spine (PNS) to the tip of 
the odontoid process 
Oropharynx Line from Posterior Nasal 
Spine (PNS) to the epiglottis 
Line from the tip of the 
odontoid process to the 
posterior-superior 
border of the 4th 
cervical vertebra (CV4) 
Line extending from 
the Posterior Nasal 
Spine (PNS) to the tip 
of the odontoid 
process 
Line from the base of the 
epiglottis to the posterior-
superior border of the 4th 
cervical vertebra (CV4) 
Hypopharynx Line extending from the base 
of the epiglottis to the inferior 
border of the symphysis 
Line extending from the 
posterior-superior 
corner of the 4th cervical 
vertebra (CV4) to the 
posterior-inferior corner 
of the 4th cervical 
vertebra (CV4) 
Line extending from 
the base of the 
epiglottis to the 
posterior-superior 
corner of the 4th 
cervical vertebra 
(CV4) 
Line extending from the 
posterior-inferior corner 
of the 4th cervical 
vertebra (CV4) to the 




Table 2. Characteristics of the included patients. 
Factor Category Hyrax 
(n=19) 
Hybrid (n=19) Keles 
(n=13) 
P 
Age (years) Mean (SD) 13.8 (1.6) 14.3 (1.7) 14.6 (1.2) 0.41* 
Gender Male – n (%) 10 (53%) 8 (42%) 2 (15%) 0.09† 
 Female – n (%) 9 (47%) 11 (58%) 11 (85%)  
CVM stage 2 – n (%) 1 (5%) 0 (0%) 0 (0%) 0.28† 
 3 – n (%) 4 (21%) 4 (21%) 0 (0%)  
 4 – n (%) 6 (32%) 8 (42%) 6 (46%)  
 5 – n (%) 6 (32%) 4 (21%) 7 (54%)  
 6 – n (%) 2 (11%) 3 (16%) 0 (0%)  
CVM stage category Pre-peak (1-3) 5 (26%) 4 (21%) 0 (0%) 0.14† 
 Mid- or post-peak (4-
6) 
14 (74%) 15 (79%) 13 (100%)  
Expansion width 
(mm) 
Mean (SD) 9.1 (2.6) 9.1 (2.2) 6.2 (2.7) 0.002* 
SNA (°) Mean (SD) 77.9 (3.5) 79.6 (4.6) 79.8 (3.4) 0.31* 
SNB (°) Mean (SD) 76.0 (4.5) 77.9 (5.1) 78.3 (2.5) 0.28* 
ANB (°) Mean (SD) 1.9 (2.9) 1.7 (2.7) 1.5 (2.7) 0.93* 
Wits (mm) Mean (SD) -1.5 (4.2) -1.4 (4.4) -1.2 (4.2) 0.99* 
SN-ML (°) Mean (SD) 36.9 (7.2) 34.8 (6.9) 33.8 (4.6) 0.42* 
NA-APog Mean (SD) 2.3 (7.1) 1.4 (6.5) 0.4 (5.4) 0.73* 
SN (mm) Mean (SD) 64.8 (3.0) 66.1 (4.0) 64.9 (2.9) 0.45* 
Co-A (mm) Mean (SD) 79.0 (5.9) 79.2 (5.5) 78.8 (3.8) 0.99* 
Co-Gn (mm) Mean (SD) 107.3 (9.1) 108.8 (6.7) 109.5 (3.9) 0.67* 
CVM, cervical vertebrae maturation method; n, number of patients; SD, standard deviation. 
* from one-way analysis of variance 
† From Fisher’s exact test CVM, cervical vertebrae maturation method; SD, standard deviation.
 
Table 3. Airway measurements and differences between before (T0) and after (T1) treatment in the three groups. 
 
Outcome Group T0 – mean (SD) T1 – mean (SD) ΔT1-T0 – mean 
(SD) 
ΔT1-T0 (%) P* 
Sinus Hyrax (n=19) 23433.05 
(9577.7) 
23813.4 (8131.1) 380.4 (2973.4) +1.6% 0.13 
 Hybrid-Hyrax (n=19) 24138.8 (7862.1) 25346.3 (8558.9) 1207.5 (1944.8) +5.0%  
 Keles (n=13) 24184.6 (8578.8) 26470.2 (7734.1) 2285.5 (3608.9) +9.5%  
Nasal cavity Hyrax (n=19) 25298.2 (9403.8) 26364.3 (8645.1) 1066.1 (8793.0) +4.2% 0.32 
 Hybrid-Hyrax (n=19) 26630.8 (5659.0) 29319.5 (5536.7) 2688.7 (3377.0) +10.1%  
 Keles (n=13) 23449.2 (7856.0) 24725.6 (6472.9) 1276.4 (5554.6) +5.4%  
Nasopharynx Hyrax (n=19) 4663.5 (2691.4) 4637.4 (2725.5) -26.1 (1403.0) -0.6% 0.04 
 Hybrid-Hyrax (n=19) 5416.8 (2194.0) 6362.4 (2443.8) 945.6 (953.6) +17.5%  
 Keles (n=13) 5585.2 (3073.1) 6764.5 (3240.8) 1179.4 (2253.2) +21.1%  
Oropharynx Hyrax (n=19) 9465.6 (2757.6) 10788.7 (4047.3) 1323.1 (2853.6) +14.0% 0.89 
 Hybrid-Hyrax (n=19) 11651.8 (6208.3) 12702.7 (5678.1) 1050.8 (2780.0) +9.0%  
 Keles (n=13) 10517.4 (3537.2) 12060.5 (1973.9) 1543.2 (2480.1) +14.7%  
Hypopharynx Hyrax (n=19) 3494.6 (1052.4) 3289.1 (1201.2) -205.5 (1008.5) -5.9% 0.45 
 Hybrid-Hyrax (n=19) 3441.9 (1430.0) 3451.3 (1290.9) 9.4 (756.5) +0.3%  
 Keles (n=13) 3273.1 (1301.7) 2924.5 (1112.6) -348.5 (1351.2) -10.6%  




2537.9 (6603.7) +3.8% 0.19 




5902.1 (5992.9) +8.3%  




3001.4 (10909.9) +4.5%  
Total excluded 
sinuses 




2157.6 (8444.9) +5.0% 0.26 




4694.5 (5087.3) +10.0%  
 Keles (n=13) 42824.9 
(11054.4) 
46475.2 (9539.3) 3650.4 (8726.9) +8.5%  
SD, standard deviation. 





Supplementary Table 1. Explorative linear regression analyses on confounders for the change in total upper airway T1-T0 across 
the whole sample (all three expansion groups). 
Factor Category b (95% CI) P 
Gender Female Reference  
 Male -2656.4 (-7087.0, 1774.2) 0.23 
    
Age Per year -952.0 (-2322.9, 418.9) 0.17 
    
CVM Stage 2 Reference 0.59 
 Stage 3 4314.3 (-12367.8, 20996.3)  
 Stage 4 2684.1 (-13432.3, 18800.4)  
 Stage 5 -432.9 (-16616.8, 15751.1)  
 Stage 6 3803.6 (-13425.5, 21032.7)  
    
CVM stage Pre-peak (CVM 1-3) Reference  
 Mid- or post-peak 
(CVM 4-6) 
-2279.2 (-7999.7, 3441.3) 0.43 
    
Expansion width Per mm -370.4 (-1168.0, 427.2) 0.36 
    
Total airway at T0 Per mm3 -0.1 (-0.3, 0) 0.02 
    
SNA Per ° 396.2 (-162.6, 954.9) 0.16 
    
SNB Per ° 345.4 (-157.5, 848.4) 0.17 
    
ANB Per ° -80.7 (-912.3, 750.9) 0.85 
    
Wits Per mm -356.3 (-885.5, 172.9) 0.18 
    
SN-MP Per ° 34.6 (-310.1, 379.2) 0.84 
    
Convexity Per ° 41.4 (-311.0, 393.7) 0.81 
    
SN Per mm -87.7 (-754.7, 579.2) 0.79 
    
Co-A Per mm -27.9 (-463.2, 407.3) 0.90 
    
Co-Gn Per mm 20.5 (-297.9, 339.0) 0.90 
b, unstandardized regression coefficient; CI, confidence interval; CVM, cervical vertebrae maturation method. * overall omnibus 





Supplementary Table 2. Adjusted linear regressions on total airway after (T1) treatment accounting for potential confounders. 
Factor Category b (95% CI) P Interaction with 
expander group† 
Expander Hyrax Reference 0.19*  
 Hybrid-Hyrax 4145.8 (-654.5, 8946.0)   
 Keles 577.3 (-4706.1, 5860.7)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001 Not tested 
     
Expander Hyrax Not tested   
 Hybrid-Hyrax Not tested   
 Keles Not tested   
Airway T0 Per mm3 Not tested   
Age Per year Not tested  0.004 
     
Expander Hyrax Reference 0.18*  
 Hybrid-Hyrax 3863.5 (-963.4, 8690.5)   
 Keles -296.3 (-5831.7, 5239.1)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
Sex Female Reference   
 Male -2332.4 (-6771.8, 2106.9) 0.30 0.93 
     
Expander Hyrax Not tested   
 Hybrid-Hyrax Not tested   
 Keles Not tested   
Airway T0 Per mm3 Not tested   
CVM stage Pre-peak Not tested  0.04 
 Mid- or post-peak Not tested   
     
Expander Hyrax Reference 0.13*  
 Hybrid-Hyrax 4193.3 (-589.4, 8976.0)   
 Keles -909.0 (-6742.8, 4924.9)   
Airway T0 Per mm3 0.9 (0.7, 1.0) <0.001  
Expansion Per mm -543.8 (-1464.5, 376.9) 0.24 0.13 
     
Expander Hyrax Reference 0.21*  
 Hybrid-Hyrax 4102.0 (-887.6, 9091.5)   
 Keles 525.3 (-4940.3, 5991.0)   
Airway T0 Per mm3 0.9 (0.7, 1.0) <0.001  
SNA Per degree 238.1 (-316.9, 793.1) 0.39 0.69 
     
Expander Hyrax Reference 0.21*  
 Hybrid-Hyrax 3974.2 (-954.3, 8902.7)   
 Keles 309.8 (-5117.8, 5737.3)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
SNB Per degree 299.5 (-189.3, 788.3) 0.22 0.53 
     
Expander Hyrax Reference 0.16*  
 Hybrid-Hyrax 4536.8 (-350.3, 9423.8)   
 Keles 877.8 (-4497.4, 6253.0)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
ANB Per degree -307.6 (-1109.0, 493.8) 0.44 0.44 
     
Expander Hyrax Reference 0.16*  
 Hybrid-Hyrax 4527.3 (-318.5, 9373.1)   
 Keles 1055.5 (-4268.3, 6379.3)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
Wits Per mm -293.6 (-797.3, 210.1) 0.25 0.30 
     
3 
 
Expander Hyrax Reference 0.17*  
 Hybrid-Hyrax 4515.7 (-434.7, 9466.1)   
 Keles 924.5 (-4570.7, 6419.8)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
SN-ML Per degree -20.6 (-358.1, 316.9) 0.90 0.06 
     
Expander Hyrax Reference 0.16*  
 Hybrid-Hyrax 4519.4 (-387.6, 9426.4)   
 Keles 828.1 (-4596.9, 6253.1)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
Convexity Per degree -87.8 (-438.5, 263.0) 0.62 0.55 
     
Expander Hyrax Reference 0.19*  
 Hybrid-Hyrax 4344.6 (-588.3   
 Keles 977.1 (-4399.2, 6353.4)   
Airway T0 Per mm3 0.8 (0.7, 1.0) <0.001  
SN Per mm 240.6 (-477.7, 958.9) 0.50 0.95 
     
Expander Hyrax Reference 0.14*  
 Hybrid-Hyrax 4703.9 (-136.9, 9544.7)   
 Keles 1046.9 (-4264.3, 6358.0)   
Airway T0 Per mm3 0.8 (0.7, 0.9) <0.001  
Co-A Per mm 290.1 (-173.1, 753.2) 0.21 0.30 
     
Expander Hyrax Reference 0.14*  
 Hybrid-Hyrax 4413.3 (-354.2, 9180.8)   
 Keles 363.0 (-4921.1, 5647.2)   
Airway T0 Per mm3 0.8 (0.6, 0.9) <0.001  
Co-Gn Per mm 297.8 (-50.5, 646.2) 0.09 0.83 
CI, confidence interval; CVM, cervical vertebral maturation. 
* from Wald test for overall differences between any of the three expansion groups. 
† tested initially in a model with expander group and baseline airway, but then dropped from the model, unless statistically 





Supplementary Table 3. Adjusted linear regressions on total airway after (T1) treatment accounting for potential confounders. 
 
  Pre-peak (CVM 1-3)  Mid- or post-peak group (CVM 4-6) 
Factor Category b (95% CI) P  b (95% CI) P 
Expander Hyrax Reference   Reference 0.73 
 Hybrid-Hyrax 12110 (3297.8, 20922.4) 0.02  1592.8 (-4033.3, 7219.0)  
 Keles - -  -568.8 (-6404.8, 5267.2)  
Airway T0 Per mm3 0.9 (0.6, 1.2) <0.001  0.8 (0.7, 1.0) <0.001 
CI, confidence interval; CVM, cervical vertebral maturation. 
* from Wald test for overall differences between any of the three expansion groups. 
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